Available to mentor
Jacob S. Aday, Ph.D. is a Research Investigator in the Department of Anesthesiology, with appointments in the Chronic Pain and Fatigue Research Center (CPFRC) as well as the Michigan Psychedelic Center (M-PsyC). He completed his undergraduate and master's degrees in Psychology at Northern Michigan University, where he worked in Dr. Adam Prus’s Neuropsychopharmacology Lab and Dr. Joshua Carlson’s Cognitive Affective Behavior and Integrative Neuroscience (CABIN) Lab. During his doctoral training, Jake was mentored by Drs. Christopher Davoli and Emily Bloesch at Central Michigan University, where they established a productive program of research centered on the emerging field of ‘psychedelic science’. During this time, he was also recruited by Drug Science, the leading independent scientific body on drugs in the UK, to be an honorary research assistant and study under Professor David Nutt. Jake then joined the Translational Psychedelic Research Program (TrPR) at the University of California, San Francisco (UCSF) as a postdoctoral researcher in 2021. There, he was mentored by Dr. Joshua Woolley on how to design, implement, and interpret complex psychedelic clinical trials. As a Research Investigator in the Department of Anesthesiology, Dr. Aday is interested in the cognitive and social effects of psychedelics, improving research methodology and safety with the drugs, and examining the potential applications of psychedelic therapy for chronic pain.
-
PhDCentral Michigan University, Mount Pleasant, MI, 2021
-
MSNorthern Michigan University, Marquette, MI, 2017
-
BSNorthern Michigan University, Marquette, MI, 2015
• Psychedelics
• Social Cognition
• Emotion
• Chronic Pain
-
Aday J. 2023 Nov;PresentationChallenges in Trial Design for Psychedelic-Assisted Therapies
-
Aday JS, Barnett BS, Grossman D, Murnane KS, Nichols CD, Hendricks PS. Psychedelic Medicine, 2023 Sep 1; 1 (3): 150 - 165.Journal ArticlePsychedelic Commercialization: A Wide-Spanning Overview of the Emerging Psychedelic Industry
DOI:10.1089/psymed.2023.0013 -
Aday J. 2023 Sep;PresentationPsychedelic science: An overview of contemporary directions
-
Glick M. 2023 Jul;Additional ScholarshipInverse: Psychedelic therapy may be coming to a headset near you
-
Aday JS, Carhart-Harris RL, Woolley JD. JAMA Psychiatry, 2023 Jun 1; 80 (6): 533 - 534.Journal ArticleEmerging Challenges for Psychedelic Therapy.
DOI:10.1001/jamapsychiatry.2023.0549 PMID: 37074690 -
Aday JS, Fang L, Carlson JM. PLoS One, 2023 18 (5): e0285839Journal ArticleEye-size effects in the dot-probe task: Greater sclera exposure predicts delayed disengagement from fearful faces.
DOI:10.1371/journal.pone.0285839 PMID: 37195990 -
Thomposon L. 2023 May;Additional ScholarshipPodcast: Learning with Lowell: Psychedelic Zeitgeist: Past, Present, and Future – Dr. Jacob Aday
-
Love S. 2023 May;Additional ScholarshipWired: Scientists Gave People Psychedelics—and Then Erased Their Memory